NCT04686305
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04686305
Title Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC (DL03)
Acronym DL03
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | TUR | POL | NLD | ITA | ISR | FRA | ESP | CAN | BRA | BEL | AUS

Facility Status City State Zip Country Details
Research Site WITHDRAWN Duarte California 91010 United States Details
Research Site WITHDRAWN Newport Beach California 92663 United States Details
Research Site RECRUITING Orange California 92868 United States Details
Research Site WITHDRAWN Santa Rosa California 95403 United States Details
Research Site WITHDRAWN Westwood Kansas 66205 United States Details
Research Site RECRUITING Baltimore Maryland 21287 United States Details
Research Site WITHDRAWN Detroit Michigan 48201 United States Details
Research Site WITHDRAWN Buffalo New York 14263 United States Details
Research Site WITHDRAWN New York New York 10029 United States Details
Research Site WITHDRAWN The Bronx New York 10461 United States Details
Research Site RECRUITING Houston Texas 77030 United States Details
Research Site RECRUITING Fairfax Virginia 22031 United States Details
Research Site WITHDRAWN Tacoma Washington 98405 United States Details
Research Site TERMINATED Adelaide 5000 Australia Details
Research Site WITHDRAWN Heidelberg 3084 Australia Details
Research Site RECRUITING Nedlands 6009 Australia Details
Research Site COMPLETED Edegem 2650 Belgium Details
Research Site NOT_YET_RECRUITING Barretos 14784-400 Brazil Details
Research Site NOT_YET_RECRUITING Porto Alegre 90035-903 Brazil Details
Research Site NOT_YET_RECRUITING São Paulo 05652-900 Brazil Details
Research Site WITHDRAWN Winnipeg Manitoba R3E 0V9 Canada Details
Research Site WITHDRAWN London Ontario N6A 5W9 Canada Details
Research Site RECRUITING Montreal Quebec H3T 1E2 Canada Details
Research Site NOT_YET_RECRUITING Fuzhou 350011 China Details
Research Site WITHDRAWN Bordeaux 33075 France Details
Research Site RECRUITING Dijon 21079 France Details
Research Site RECRUITING Pierre-Bénite 69495 France Details
Research Site RECRUITING Saint-Herblain 44800 France Details
Research Site RECRUITING Villejuif 94805 France Details
Research Site RECRUITING Kfar Saba 4428164 Israel Details
Research Site RECRUITING Tel Litwinsky 52620 Israel Details
Research Site COMPLETED Milan 20133 Italy Details
Research Site RECRUITING Milan 20162 Italy Details
Research Site RECRUITING Monza 20052 Italy Details
Research Site RECRUITING Napoli 80131 Italy Details
Research Site RECRUITING Padua 35128 Italy Details
Research Site RECRUITING George Town 10450 Malaysia Details
Research Site RECRUITING Kuala Lumpur 59100 Malaysia Details
Research Site RECRUITING Kuala Selangor 62250 Malaysia Details
Research Site RECRUITING Kuching 93586 Malaysia Details
Research Site COMPLETED Amsterdam 1066 CX Netherlands Details
Research Site RECRUITING Bacolod 6100 Philippines Details
Research Site WITHDRAWN Cebu City 6000 Philippines Details
Research Site WITHDRAWN City of Taguig 1634 Philippines Details
Research Site TERMINATED Davao City PH-8000 Philippines Details
Research Site TERMINATED Manila 1000 Philippines Details
Research Site WITHDRAWN Manila 1015 Philippines Details
Research Site RECRUITING Quezon City 1100 Philippines Details
Research Site RECRUITING Quezon City 1112 Philippines Details
Research Site TERMINATED San Juan City 1500 Philippines Details
Research Site RECRUITING Gdansk 80-214 Poland Details
Research Site RECRUITING Krakow 30-727 Poland Details
Research Site RECRUITING Olsztyn 10-357 Poland Details
Research Site TERMINATED Tomaszów Mazowiecki 97-200 Poland Details
Research Site RECRUITING Warsaw 02-781 Poland Details
Research Site COMPLETED Singapore 119228 Singapore Details
Research Site COMPLETED Singapore 168583 Singapore Details
Research Site COMPLETED Singapore 308433 Singapore Details
Research Site RECRUITING Cheongju-si 28644 South Korea Details
Research Site RECRUITING Goyang-si 10408 South Korea Details
Research Site RECRUITING Jinju 52727 South Korea Details
Research Site RECRUITING Seoul 03722 South Korea Details
Research Site WITHDRAWN Seoul 05505 South Korea Details
Research Site RECRUITING Seoul 06351 South Korea Details
Research Site WITHDRAWN Badalona 08013 Spain Details
Research Site WITHDRAWN Madrid 28041 Spain Details
Research Site WITHDRAWN Seville 41013 Spain Details
Research Site WITHDRAWN Valencia 46010 Spain Details
Research Site RECRUITING Kaohsiung City 833 Taiwan Details
Research Site RECRUITING Taichung 402 Taiwan Details
Research Site RECRUITING Taichung 40705 Taiwan Details
Research Site RECRUITING Tainan 70403 Taiwan Details
Research Site RECRUITING Taipei 100 Taiwan Details
Research Site RECRUITING Taipei 11217 Taiwan Details
Research Site RECRUITING Taipei 235 Taiwan Details
Research Site RECRUITING Taoyuan District 333 Taiwan Details
Research Site RECRUITING Bangkok 10300 Thailand Details
Research Site RECRUITING Bangkok 10330 Thailand Details
Research Site COMPLETED Hat Yai 90110 Thailand Details
Research Site RECRUITING Khon Kaen 40002 Thailand Details
Research Site NOT_YET_RECRUITING Muang 22000 Thailand Details
Research Site RECRUITING Muang 50200 Thailand Details
Research Site RECRUITING Ankara 06800 Turkey (Türkiye) Details
Research Site RECRUITING Ankara 6200 Turkey (Türkiye) Details
Research Site RECRUITING Bornova-Izmir 35100 Turkey (Türkiye) Details
Research Site NOT_YET_RECRUITING Istanbul 31755 Turkey (Türkiye) Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field